Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/30/23 17:03 | 3/28/23 | DICE | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | DT | P.m | 14,799 | 29.07 | 0 | 509 | 7 | 7,857 | I | |||||||||||||||
3/27/23 17:01 | 3/23/23 | DICE | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | DT | P.m | 13,457 | 26.99 | 0 | 499 | 7 | 7,347 | I | |||||||||||||||
10/19/22 16:32 | 10/17/22 | DICE | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | DT | P | 59,860 | 36.50 | 0 | 1,640 | 31 | 6,849 | I | |||||||||||||||
9/20/21 21:19 | 9/17/21 | DICE | Health | Drug | Pharmaceutical Preparations | Northpond Ventures Gp, LLC | MD | T | P.d | 3,995 | 17.00 | 0 | 235 | 4 | 5,896 | I | |||||||||||||||
9/20/21 16:30 | 9/17/21 | DICE | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | DT | P.d | 23,800 | 17.00 | 0 | 1,400 | 786 | I | ||||||||||||||||
9/16/21 21:30 | 9/15/21 | DICE | Health | Drug | Pharmaceutical Preparations | Scopa James Paul | CA | D | P.d | 102 | 17.00 | 0 | 6 | 12 | 56 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |